- Home
- PHVS vs EEX Comparison
PHVS vs EEX Comparison
Compare PHVS & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- EEX
- Stock Information
- Founded
- PHVS 2015
- EEX 2013
- Country
- PHVS Netherlands
- EEX United States
- Employees
- PHVS N/A
- EEX N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- EEX Advertising
- Sector
- PHVS Health Care
- EEX Consumer Discretionary
- Exchange
- PHVS Nasdaq
- EEX Nasdaq
- Market Cap
- PHVS 1.0B
- EEX 883.0M
- IPO Year
- PHVS 2021
- EEX 2017
- Fundamental
- Price
- PHVS $22.29
- EEX $5.07
- Analyst Decision
- PHVS Buy
- EEX Strong Buy
- Analyst Count
- PHVS 6
- EEX 2
- Target Price
- PHVS $35.67
- EEX $7.90
- AVG Volume (30 Days)
- PHVS 67.6K
- EEX 120.2K
- Earning Date
- PHVS 11-13-2024
- EEX 10-30-2024
- Dividend Yield
- PHVS N/A
- EEX 1.19%
- EPS Growth
- PHVS N/A
- EEX N/A
- EPS
- PHVS N/A
- EEX N/A
- Revenue
- PHVS N/A
- EEX $393,500,000.00
- Revenue This Year
- PHVS N/A
- EEX $5.54
- Revenue Next Year
- PHVS N/A
- EEX $7.75
- P/E Ratio
- PHVS N/A
- EEX N/A
- Revenue Growth
- PHVS N/A
- EEX 4.96
- 52 Week Low
- PHVS $15.37
- EEX $3.92
- 52 Week High
- PHVS $33.00
- EEX $7.05
- Technical
- Relative Strength Index (RSI)
- PHVS 54.95
- EEX 65.46
- Support Level
- PHVS $18.81
- EEX $4.65
- Resistance Level
- PHVS $21.85
- EEX $4.81
- Average True Range (ATR)
- PHVS 1.44
- EEX 0.17
- MACD
- PHVS -0.17
- EEX 0.06
- Stochastic Oscillator
- PHVS 52.81
- EEX 99.40
About PHVS Pharvaris N.V.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .
About EEX Emerald Holding Inc.
Emerald Holding Inc is an operator of B2B trade shows in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry, Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. Majority of the revenue for the company is generated from its Connections segment.